Coupang Inc vs Tempus AI — how do they compare? Coupang Inc trades at $16.36 (market cap $29.34B), while Tempus AI trades at $54.46 (market cap $9.85B). The key difference: Coupang Inc is far larger — about 3× Tempus AI's market cap, and Tempus AI is trading nearer its 52-week high, Coupang Inc nearer its low. Which is the better fit depends on your goals.
| CPNG | TEM | |
|---|---|---|
Market Cap | $29.34B | $9.85B |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $33.53 | $103.25 |
52-Week Low | $15.12 | $41.55 |
Enterprise Value | $28.86B | $10.48B |
Signals from Pluang's Aura AI — not financial advice
Coupang (CPNG) trades at $16.42, up 1.42% on the day, with technical indicators showing a neutral to bearish bias as the stock consolidates near key support levels. The company reported mixed Q2 2026 results with revenue acceleration but missed earnings expectations, while maintaining strong revenue growth trends and positive operating cash flow of $1.77 billion in 2025. Recent news highlights Coupang's debut on the Fortune Global 500 and ongoing recovery from a data breach incident.
Despite near-term earnings pressure and regulatory challenges, Coupang maintains dominant market position in South Korean e-commerce with expanding Taiwan operations. Wall Street remains overwhelmingly bullish with 87.5% buy ratings and a $23.38 consensus price target representing 42% upside potential, though investors should monitor execution on profitability targets and resolution of the $422 million regulatory fine.
Tempus AI (TEM) trades at $54.61, down 0.82% with a bullish technical outlook despite negative profitability. The company shows strong revenue growth with 2026 revenue guidance raised to $1.4B, though net losses persist. Recent Q2 earnings beat expectations with a narrower loss of $0.04 per share versus $0.14 expected. Technical indicators show bullish momentum with support at $54 and resistance at $57.
Investment outlook balances growth potential against profitability challenges. Analyst consensus is strongly bullish with 61.5% buy ratings and $61.57 price target, representing 13% upside. Key risks include sustained negative cash flow from operations and high valuation multiples amid ongoing losses. The Personalis acquisition expands MRD testing capabilities but integration execution remains a watchpoint.
Trailing returns across standard periods
Latest headlines on both assets
Coupang Inc is an e-commerce company. The company sells apparel, electronics, footwear, food products, furniture, nutritional supplements, and other products. Its segments include Product Commerce and Growth Initiatives.
Read more on CPNG →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →